We are live on ! Find out more
BAM

Brave Asset Management Portfolio holdings

AUM $467M
1-Year Est. Return 33.05%
This Fund
S&P 500
This Quarter Est. Return
+4.99%
1 Year Est. Return
+33.05%
3 Year Est. Return
+76.26%
5 Year Est. Return
+83.39%
10 Year Est. Return
+335.31%
AUM
$412M
AUM Growth
+$19.3M
Cap. Flow
+$4.45M
Cap. Flow %
1.08%
Top 10 Hldgs %
64.87%
Holding
177
New
18
Increased
17
Reduced
32
Closed
7

Top Buys

Rank Stock Value
1
IAU icon
iShares Gold Trust
IAU
+$24.6M
2
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$3.09M
3
VEU icon
Vanguard FTSE All-World ex-US ETF
VEU
+$1.33M
4
EFV icon
iShares MSCI EAFE Value ETF
EFV
+$1.07M
5
BMY icon
Bristol-Myers Squibb
BMY
+$300K

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$29M
2
DIS icon
Walt Disney
DIS
+$4.38M
3
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$510K
4
AMZN icon
Amazon
AMZN
+$318K
5
AI icon
C3.ai
AI
+$288K

Sector Composition

Rank Sector Weight
1 Technology 12.1%
2 Communication Services 8.03%
3 Financials 8%
4 Consumer Discretionary 2.96%
5 Healthcare 2.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QS icon
151
QuantumScape Corp
QS
$3.28B
$75.9K 0.02%
13,200
-9,000
-41% -$55.4K
DHF
152
BNY Mellon High Yield Strategies Fund
DHF
$174M
$67.5K 0.02%
25,100
– –
RXRX icon
153
Recursion Pharmaceuticals
RXRX
$1.69B
$65.9K 0.02%
10,000
– –
ALT icon
154
Altimmune
ALT
$583M
$61.4K 0.01%
10,000
– –
PLUG icon
155
Plug Power
PLUG
$2.9B
$53.1K 0.01%
23,500
– –
ORGN
156
DELISTED
Origin Materials
ORGN
$41.6K 0.01%
900
– –
EDIT icon
157
Editas Medicine
EDIT
$407M
$36.6K 0.01%
10,725
– –
CHPT icon
158
ChargePoint
CHPT
$143M
$31.5K 0.01%
1,150
– –
MIN
159
Aberdeen Intermediate Income Fund
MIN
$274M
$27.2K 0.01%
10,000
– –
BLNK icon
160
Blink Charging
BLNK
$78M
$24.1K 0.01%
14,000
– –
LEV
161
DELISTED
The Lion Electric Company
LEV
$23.8K 0.01%
35,000
– –
ONCY
162
Oncolytics Biotech
ONCY
$92.5M
$22K 0.01%
25,000
– –
ASTLW icon
163
Algoma Steel Group Warrant
ASTLW
$242K
$17.3K ﹤0.01%
10,000
– –
LAZR
164
DELISTED
Luminar Technologies
LAZR
$13.2K ﹤0.01%
977
– –
MVST icon
165
Microvast
MVST
$274M
$12.7K ﹤0.01%
51,000
– –
ACHL
166
DELISTED
Achilles Therapeutics
ACHL
$10.2K ﹤0.01%
10,000
– –
AMLI
167
DELISTED
American Lithium Corp. Common Stock
AMLI
$8.51K ﹤0.01%
15,000
– –
KOPN icon
168
Kopin
KOPN
$693M
$7.3K ﹤0.01%
10,000
– –
LUCYW icon
169
Innovative Eyewear Inc Series A Warrants 8/16/27
LUCYW
$87.4K
$1.44K ﹤0.01%
+31,388
New +$1.85K
RBOT.WS
170
DELISTED
Vicarious Surgical Inc Warrants
RBOT.WS
$1.13K ﹤0.01%
+25,000
New +$1.04K
AI icon
171
C3.ai
AI
$1.51B
– –
-9,961
Closed -$288K
CRSP icon
172
CALL
CRISPR Therapeutics
CRSP
$4.88B
– –
-700
Closed -$37.8K
DNA icon
173
Ginkgo Bioworks
DNA
$584M
– –
-625
Closed -$8.36K
LAC
174
Lithium Americas
LAC
$1.05B
– –
-14,000
Closed -$37.5K
PLTR icon
175
Palantir
PLTR
$301B
– –
-9,600
Closed -$243K
4 5 6
7
8

Similar funds

VCM
Verde Capital Management Clarkston, Michigan $468M AUM 17.35% 1-Year Est. Return
SP
Solel Partners Boston, Massachusetts $468M AUM 2.45% 1-Year Est. Return
KWS
Keystone Wealth Services Palm Desert, California $468M AUM 22.94% 1-Year Est. Return
PC
Panview Capital Hong Kong $467M AUM 70.9% 1-Year Est. Return
LN
Lightrock Netherlands Utrecht, Netherlands $468M AUM 43.06% 1-Year Est. Return
SCA
Stieven Capital Advisors St. Louis, Missouri $468M AUM 15.94% 1-Year Est. Return
HP
Hartree Partners New York $467M AUM 66.71% 1-Year Est. Return
JHC
Jones Hill Capital New York $466M AUM

Brave Asset Management's Q3 2024 Portfolio in Review

As of Q3 2024, Brave Asset Management held 177 positions worth $412M, up 4.9% from $393M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Brave Asset Management's Q3 2024 filing shows 18 new, 17 increased, 32 reduced and 7 closed positions. Its largest new stake was iShares Gold Trust: 526,536 shares worth $26.2M. The largest sale was Invesco QQQ Trust, an estimated $29M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Communication Services and Financials.

  • Brave Asset Management's largest Q3 2024 buy was iShares Gold Trust: 526,536 shares worth $26.2M.
  • Brave Asset Management added most to iShares Core US Aggregate Bond ETF in Q3 2024, an estimated $3.09M increase.
  • Brave Asset Management's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $29M.
  • Brave Asset Management fully exited C3.ai in Q3 2024, selling an estimated $288K.
  • Brave Asset Management's ten largest holdings make up 65% of its $412M portfolio in Q3 2024.
  • Brave Asset Management opened 18 new positions and closed 7 in Q3 2024.
  • Brave Asset Management's portfolio value rose 4.9% quarter-over-quarter to $412M.

Based on Brave Asset Management's 13F filing for Q3 2024, filed 10 Oct 2024.